- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退,要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
24Q3 (20) | 54 | 10.2 | 10.2 | 0.05 | -68.75 | 150.0 | 0.06 | -33.33 | 140.0 | 0.24 | 26.32 | 163.16 | 0.68 | 4.62 | 36.0 | 35.47 | -12.81 | 72.27 | 7.25 | -9.26 | 144.18 | 3.92 | -67.09 | 139.28 | 0.05 | 0.0 | 162.5 | 0.03 | -62.5 | 160.0 | 7.54 | -42.75 | 179.87 | 3.92 | -67.09 | 139.28 | 35.65 | 182.29 | 97.62 |
24Q2 (19) | 49 | 0.0 | 0.0 | 0.16 | 433.33 | 0 | 0.09 | 228.57 | 200.0 | 0.19 | 533.33 | 167.86 | 0.65 | 66.67 | 14.04 | 40.68 | 17.44 | 57.92 | 7.99 | 190.18 | 195.8 | 11.91 | 208.55 | 3741.94 | 0.05 | 266.67 | 200.0 | 0.08 | 700.0 | 0 | 13.17 | 274.15 | 1525.93 | 11.91 | 208.55 | 3741.94 | 37.50 | 272.44 | 151.78 |
24Q1 (18) | 49 | 0.0 | 0.0 | 0.03 | 111.54 | 110.34 | -0.07 | 75.0 | 73.08 | 0.03 | 104.69 | 110.34 | 0.39 | 8.33 | -22.0 | 34.64 | 418.56 | 181.63 | -8.86 | 77.45 | 68.13 | 3.86 | 110.82 | 113.73 | -0.03 | 78.57 | 78.57 | 0.01 | 107.69 | 107.14 | 3.52 | 110.09 | 112.78 | 3.86 | 110.82 | 113.73 | -9.84 | -24.23 | -5.84 |
23Q4 (17) | 49 | 0.0 | 0.0 | -0.26 | -160.0 | -85.71 | -0.28 | -86.67 | -154.55 | -0.64 | -68.42 | -357.14 | 0.36 | -28.0 | -52.0 | 6.68 | -67.56 | -64.26 | -39.29 | -139.43 | -488.17 | -35.69 | -257.62 | -287.51 | -0.14 | -75.0 | -180.0 | -0.13 | -160.0 | -85.71 | -34.90 | -269.7 | -304.4 | -35.69 | -257.62 | -287.51 | -20.14 | -80.00 | -76.67 |
23Q3 (16) | 49 | 0.0 | 0.0 | -0.10 | 0 | 0 | -0.15 | -66.67 | -66.67 | -0.38 | -35.71 | 0 | 0.5 | -12.28 | -16.67 | 20.59 | -20.07 | -10.52 | -16.41 | -96.76 | -106.16 | -9.98 | -3319.35 | -2395.0 | -0.08 | -60.0 | -60.0 | -0.05 | 0 | 0 | -9.44 | -1265.43 | -2584.21 | -9.98 | -3319.35 | -2395.0 | 0.86 | 50.00 | -0.65 |
23Q2 (15) | 49 | 0.0 | 0.0 | 0.00 | 100.0 | -100.0 | -0.09 | 65.38 | -550.0 | -0.28 | 3.45 | -2900.0 | 0.57 | 14.0 | -12.31 | 25.76 | 109.43 | -15.98 | -8.34 | 70.0 | -656.0 | 0.31 | 101.1 | -95.95 | -0.05 | 64.29 | -600.0 | 0 | 100.0 | -100.0 | 0.81 | 102.94 | -90.17 | 0.31 | 101.1 | -95.95 | -9.66 | -3.57 | -35.49 |
23Q1 (14) | 49 | 0.0 | 0.0 | -0.29 | -107.14 | -222.22 | -0.26 | -136.36 | -188.89 | -0.29 | -107.14 | -222.22 | 0.5 | -33.33 | -12.28 | 12.30 | -34.19 | -60.64 | -27.80 | -316.17 | -326.38 | -28.11 | -205.21 | -244.06 | -0.14 | -180.0 | -250.0 | -0.14 | -100.0 | -180.0 | -27.54 | -219.12 | -292.31 | -28.11 | -205.21 | -244.06 | -4.16 | -53.57 | -79.29 |
22Q4 (13) | 49 | 0.0 | 0.0 | -0.14 | 0 | -133.33 | -0.11 | -22.22 | 15.38 | -0.14 | 0 | -142.42 | 0.75 | 25.0 | 15.38 | 18.69 | -18.77 | -33.37 | -6.68 | 16.08 | 27.47 | -9.21 | -2202.5 | -107.9 | -0.05 | 0.0 | 16.67 | -0.07 | 0 | -133.33 | -8.63 | -2371.05 | -183.88 | -9.21 | -2202.5 | -107.9 | 8.65 | -50.00 | -286.11 |
22Q3 (12) | 49 | 0.0 | 0.0 | 0.00 | -100.0 | 0 | -0.09 | -550.0 | -325.0 | 0.00 | -100.0 | -100.0 | 0.6 | -7.69 | -10.45 | 23.01 | -24.95 | -35.98 | -7.96 | -630.67 | -229.22 | -0.40 | -105.22 | -500.0 | -0.05 | -600.0 | -225.0 | 0 | -100.0 | 0 | 0.38 | -95.39 | -85.33 | -0.40 | -105.22 | -500.0 | 3.17 | 55.56 | -213.89 |
22Q2 (11) | 49 | 0.0 | 0.0 | 0.10 | 211.11 | -56.52 | 0.02 | 122.22 | -93.94 | 0.01 | 111.11 | -97.37 | 0.65 | 14.04 | -50.0 | 30.66 | -1.89 | -6.55 | 1.50 | 123.01 | -89.69 | 7.66 | 193.76 | -12.36 | 0.01 | 125.0 | -94.74 | 0.05 | 200.0 | -54.55 | 8.24 | 217.38 | -13.17 | 7.66 | 193.76 | -12.36 | 0.86 | 80.56 | 76.50 |
22Q1 (10) | 49 | 0.0 | 0.0 | -0.09 | -50.0 | -156.25 | -0.09 | 30.77 | -181.82 | -0.09 | -127.27 | -156.25 | 0.57 | -12.31 | -36.67 | 31.25 | 11.41 | -14.1 | -6.52 | 29.21 | -186.59 | -8.17 | -84.42 | -195.67 | -0.04 | 33.33 | -157.14 | -0.05 | -66.67 | -162.5 | -7.02 | -130.92 | -173.2 | -8.17 | -84.42 | -195.67 | -7.65 | -25.00 | -197.12 |
21Q4 (9) | 49 | 0.0 | 0.0 | -0.06 | 0 | -126.09 | -0.13 | -425.0 | -218.18 | 0.33 | -15.38 | -2.94 | 0.65 | -2.99 | -39.25 | 28.05 | -21.95 | -16.02 | -9.21 | -249.51 | -250.0 | -4.43 | -4530.0 | -141.83 | -0.06 | -250.0 | -185.71 | -0.03 | 0 | -127.27 | -3.04 | -217.37 | -127.69 | -4.43 | -4530.0 | -141.83 | -25.73 | -50.00 | -256.44 |
21Q3 (8) | 49 | 0.0 | 0.0 | 0.00 | -100.0 | 100.0 | 0.04 | -87.88 | 0.0 | 0.39 | 2.63 | 254.55 | 0.67 | -48.46 | -23.86 | 35.94 | 9.54 | 6.14 | 6.16 | -57.66 | 103.97 | 0.10 | -98.86 | 112.82 | 0.04 | -78.95 | 33.33 | 0 | -100.0 | 100.0 | 2.59 | -72.71 | 517.74 | 0.10 | -98.86 | 112.82 | -2.01 | -28.12 | 56.06 |
21Q2 (7) | 49 | 0.0 | 0.0 | 0.23 | 43.75 | 360.0 | 0.33 | 200.0 | 1750.0 | 0.38 | 137.5 | 216.67 | 1.3 | 44.44 | 54.76 | 32.81 | -9.81 | -3.22 | 14.55 | 93.23 | 48400.0 | 8.74 | 2.34 | 198.29 | 0.19 | 171.43 | 0 | 0.11 | 37.5 | 450.0 | 9.49 | -1.04 | 217.39 | 8.74 | 2.34 | 198.29 | 14.27 | 6.66 | 100.00 |
21Q1 (6) | 49 | 0.0 | 0.0 | 0.16 | -30.43 | 128.57 | 0.11 | 0.0 | 83.33 | 0.16 | -52.94 | 128.57 | 0.9 | -15.89 | 2.27 | 36.38 | 8.92 | 0.33 | 7.53 | 22.64 | 120.18 | 8.54 | -19.36 | 112.97 | 0.07 | 0.0 | 133.33 | 0.08 | -27.27 | 100.0 | 9.59 | -12.66 | 118.45 | 8.54 | -19.36 | 112.97 | 2.85 | 1184.79 | 87.50 |
20Q4 (5) | 49 | 0.0 | 0.0 | 0.23 | 2400.0 | -48.89 | 0.11 | 175.0 | -35.29 | 0.34 | 209.09 | -33.33 | 1.07 | 21.59 | -4.46 | 33.40 | -1.36 | -12.79 | 6.14 | 103.31 | -30.39 | 10.59 | 1457.69 | -46.27 | 0.07 | 133.33 | -30.0 | 0.11 | 1200.0 | -50.0 | 10.98 | 1870.97 | -45.07 | 10.59 | 1457.69 | -46.27 | - | - | 0.00 |
20Q3 (4) | 49 | 0.0 | 0.0 | -0.01 | -120.0 | 0.0 | 0.04 | 300.0 | 0.0 | 0.11 | -8.33 | 0.0 | 0.88 | 4.76 | 0.0 | 33.86 | -0.12 | 0.0 | 3.02 | 9966.67 | 0.0 | -0.78 | -126.62 | 0.0 | 0.03 | 0 | 0.0 | -0.01 | -150.0 | 0.0 | -0.62 | -120.74 | 0.0 | -0.78 | -126.62 | 0.0 | - | - | 0.00 |
20Q2 (3) | 49 | 0.0 | 0.0 | 0.05 | -28.57 | 0.0 | -0.02 | -133.33 | 0.0 | 0.12 | 71.43 | 0.0 | 0.84 | -4.55 | 0.0 | 33.90 | -6.51 | 0.0 | 0.03 | -99.12 | 0.0 | 2.93 | -26.93 | 0.0 | 0 | -100.0 | 0.0 | 0.02 | -50.0 | 0.0 | 2.99 | -31.89 | 0.0 | 2.93 | -26.93 | 0.0 | - | - | 0.00 |
20Q1 (2) | 49 | 0.0 | 0.0 | 0.07 | -84.44 | 0.0 | 0.06 | -64.71 | 0.0 | 0.07 | -86.27 | 0.0 | 0.88 | -21.43 | 0.0 | 36.26 | -5.33 | 0.0 | 3.42 | -61.22 | 0.0 | 4.01 | -79.65 | 0.0 | 0.03 | -70.0 | 0.0 | 0.04 | -81.82 | 0.0 | 4.39 | -78.04 | 0.0 | 4.01 | -79.65 | 0.0 | - | - | 0.00 |
19Q4 (1) | 49 | 0.0 | 0.0 | 0.45 | 0.0 | 0.0 | 0.17 | 0.0 | 0.0 | 0.51 | 0.0 | 0.0 | 1.12 | 0.0 | 0.0 | 38.30 | 0.0 | 0.0 | 8.82 | 0.0 | 0.0 | 19.71 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.22 | 0.0 | 0.0 | 19.99 | 0.0 | 0.0 | 19.71 | 0.0 | 0.0 | - | - | 0.00 |
年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
---|---|---|---|---|---|---|---|---|---|---|
2024/10 | 0.26 | 28.08 | 87.17 | 1.98 | 16.11 | 0.71 | N/A | 本月營收較去年同期增加87.18%,主要係新增子公司業務所致。 | ||
2024/9 | 0.2 | -20.97 | 54.76 | 1.72 | 9.87 | 0.68 | 0.72 | 本月營收較去年同期增加54.76%,主要係新增子公司業務所致。 | ||
2024/8 | 0.26 | 12.8 | 52.79 | 1.52 | 5.81 | 0.7 | 0.7 | 本月營收較去年同期增加52.79%,主要係新增子公司業務所致。 | ||
2024/7 | 0.23 | 2.62 | 11.63 | 1.27 | -0.35 | 0.7 | 0.7 | - | ||
2024/6 | 0.22 | -13.73 | 62.09 | 1.04 | -2.62 | 0.65 | 0.77 | 本月營收較去年同期增加62.10%,主要係新增子公司業務所致。 | ||
2024/5 | 0.26 | 43.73 | 16.7 | 0.82 | -12.03 | 0.64 | 0.78 | - | ||
2024/4 | 0.18 | -14.91 | -15.6 | 0.57 | -20.83 | 0.44 | 1.14 | - | ||
2024/3 | 0.21 | 310.35 | -4.73 | 0.39 | -23.01 | 0.39 | 1.42 | - | ||
2024/2 | 0.05 | -60.46 | -62.83 | 0.18 | -37.05 | 0.28 | 1.96 | 本月營收較去年同期減少 62.84%,主要係消化器類癌症用藥結束代理減少營收所致。 | ||
2024/1 | 0.13 | 26.97 | -13.27 | 0.13 | -13.27 | 0.35 | 1.57 | - | ||
2023/12 | 0.1 | -15.38 | -54.45 | 1.93 | -25.39 | 0.36 | 1.53 | 本月營收較去年同期減少54.46%,主要係健檢事業營收減少所致。 | ||
2023/11 | 0.12 | -13.13 | -57.15 | 1.83 | -22.65 | 0.39 | 1.42 | 本月營收較去年同期減少57.16%,主要係健檢事業營收減少所致。 | ||
2023/10 | 0.14 | 5.9 | -46.32 | 1.71 | -18.02 | 0.44 | 1.26 | - | ||
2023/9 | 0.13 | -21.98 | -41.97 | 1.57 | -14.03 | 0.5 | 1.22 | - | ||
2023/8 | 0.17 | -17.57 | -30.53 | 1.44 | -10.12 | 0.51 | 1.21 | - | ||
2023/7 | 0.2 | 49.01 | 50.81 | 1.27 | -6.51 | 0.56 | 1.09 | 本月營收較去年同期增加50.82%,主要係健檢事業營收增加所致。 | ||
2023/6 | 0.14 | -37.89 | -21.35 | 1.07 | -12.79 | 0.57 | 1.22 | - | ||
2023/5 | 0.22 | 3.94 | -6.26 | 0.93 | -11.38 | 0.65 | 1.06 | - | ||
2023/4 | 0.21 | -3.96 | -15.2 | 0.72 | -12.84 | 0.57 | 1.22 | - | ||
2023/3 | 0.22 | 60.09 | 12.21 | 0.5 | -11.82 | 0.5 | 1.61 | - | ||
2023/2 | 0.14 | -7.73 | 10.09 | 0.29 | -24.28 | 0.51 | 1.59 | - | ||
2023/1 | 0.15 | -33.31 | -41.22 | 0.15 | -41.22 | 0.65 | 1.24 | - | ||
2022/12 | 0.22 | -20.4 | 9.64 | 2.59 | -26.45 | 0.76 | 1.45 | - | ||
2022/11 | 0.28 | 8.82 | 29.34 | 2.36 | -28.66 | 0.76 | 1.45 | - | ||
2022/10 | 0.26 | 14.48 | 11.52 | 2.08 | -32.72 | 0.72 | 1.52 | - | ||
2022/9 | 0.22 | -6.59 | 11.75 | 1.83 | -36.27 | 0.6 | 2.1 | - | ||
2022/8 | 0.24 | 78.93 | -10.01 | 1.6 | -39.89 | 0.55 | 2.3 | - | ||
2022/7 | 0.13 | -22.29 | -33.17 | 1.36 | -43.22 | 0.54 | 2.33 | - | ||
2022/6 | 0.17 | -25.97 | -72.71 | 1.23 | -44.14 | 0.65 | 2.11 | 本月營收較去年同期減少 72.72%,主要係熟齡女性保健食品結束代理減少營收所致。 | ||
2022/5 | 0.23 | -5.96 | -29.62 | 1.05 | -32.56 | 0.68 | 2.04 | - | ||
2022/4 | 0.25 | 27.08 | -25.46 | 0.82 | -33.36 | 0.57 | 2.43 | - | ||
2022/3 | 0.2 | 57.07 | -35.12 | 0.57 | -36.28 | 0.57 | 1.8 | - | ||
2022/2 | 0.12 | -50.74 | -50.06 | 0.38 | -36.87 | 0.58 | 1.78 | 本月較去年同期減少50.07%,主係受新冠肺炎疫情亦趨嚴峻而影響營收所致。 | ||
2022/1 | 0.25 | 24.39 | -27.43 | 0.25 | -27.43 | 0.67 | 1.53 | - | ||
2021/12 | 0.2 | -6.1 | -20.15 | 3.52 | -2.55 | 0.65 | 1.69 | - | ||
2021/11 | 0.22 | -6.17 | -46.29 | 3.31 | -1.21 | 0.65 | 1.7 | - | ||
2021/10 | 0.23 | 14.72 | -32.9 | 3.1 | 4.93 | 0.7 | 1.57 | - | ||
2021/9 | 0.2 | -24.78 | -38.49 | 2.87 | 9.91 | 0.67 | 1.82 | - | ||
2021/8 | 0.27 | 32.87 | -5.88 | 2.66 | 16.84 | 1.1 | 1.11 | - | ||
2021/7 | 0.2 | -68.27 | -26.11 | 2.4 | 20.08 | 1.17 | 1.05 | - | ||
2021/6 | 0.63 | 90.95 | 121.48 | 2.2 | 27.36 | 1.3 | 1.06 | 本月營收較去年同期增加 121.49%,主要係熟齡女性保健食品銷售增加所致。 | ||
2021/5 | 0.33 | -0.4 | 26.47 | 1.56 | 8.65 | 0.97 | 1.42 | - | ||
2021/4 | 0.33 | 10.6 | 12.72 | 1.23 | 4.68 | 0.88 | 1.55 | - | ||
2021/3 | 0.3 | 20.9 | -8.06 | 0.9 | 1.98 | 0.9 | 2.04 | - | ||
2021/2 | 0.25 | -28.42 | -9.86 | 0.6 | 7.92 | 0.85 | 2.15 | - | ||
2021/1 | 0.35 | 36.88 | 25.69 | 0.35 | 25.69 | 1.0 | 1.82 | - | ||
2020/12 | 0.25 | -36.84 | -47.26 | 3.61 | -16.67 | 1.0 | 1.55 | - | ||
2020/11 | 0.4 | 17.22 | 39.62 | 3.35 | -12.84 | 1.07 | 1.44 | - | ||
2020/10 | 0.34 | 5.15 | -5.28 | 2.95 | -17.09 | 0.95 | 1.62 | - | ||
2020/9 | 0.33 | 15.09 | 23.5 | 2.61 | -18.43 | 0.88 | 1.63 | - | ||
2020/8 | 0.28 | 4.31 | -30.16 | 2.28 | -22.21 | 0.84 | 1.71 | - | ||
2020/7 | 0.27 | -4.89 | -20.46 | 2.0 | -20.93 | 0.82 | 1.76 | - | ||
2020/6 | 0.29 | 9.03 | -24.49 | 1.72 | -21.0 | 0.84 | 1.8 | - | ||
2020/5 | 0.26 | -11.23 | -28.88 | 1.44 | -20.27 | 0.89 | 1.72 | - | ||
2020/4 | 0.3 | -9.79 | -23.86 | 1.18 | -18.06 | 0.9 | 1.69 | - | ||
2020/3 | 0.33 | 18.52 | 7.02 | 0.88 | -15.91 | 0.88 | 1.61 | - | ||
2020/2 | 0.28 | -0.18 | 27.8 | 0.55 | -25.38 | 1.04 | 1.37 | - | ||
2020/1 | 0.28 | -42.57 | -47.28 | 0.28 | -47.28 | 1.05 | 1.36 | - | ||
2019/12 | 0.48 | 67.21 | 0.53 | 4.33 | -18.8 | 0.0 | N/A | - | ||
2019/11 | 0.29 | -20.47 | -21.14 | 3.85 | -20.71 | 0.0 | N/A | - |
加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 (10) | 49 | 0.0 | -0.64 | 0 | -0.78 | 0 | 1.93 | -25.19 | 17.35 | -32.04 | -21.28 | 0 | -16.49 | 0 | -0.41 | 0 | -0.31 | 0 | -0.32 | 0 |
2022 (9) | 49 | 0.0 | -0.14 | 0 | -0.28 | 0 | 2.58 | -26.7 | 25.53 | -23.65 | -4.86 | 0 | -2.64 | 0 | -0.13 | 0 | -0.05 | 0 | -0.07 | 0 |
2021 (8) | 49 | 0.0 | 0.33 | -2.94 | 0.35 | 59.09 | 3.52 | -4.35 | 33.44 | -2.54 | 6.77 | 102.69 | 4.61 | 1.77 | 0.24 | 100.0 | 0.21 | 16.67 | 0.16 | -5.88 |
2020 (7) | 49 | 0.0 | 0.34 | -33.33 | 0.22 | 0 | 3.68 | -15.01 | 34.31 | 8.1 | 3.34 | 1236.0 | 4.53 | -22.56 | 0.12 | 1100.0 | 0.18 | -30.77 | 0.17 | -32.0 |
2019 (6) | 49 | -2.0 | 0.51 | 0 | 0.00 | 0 | 4.33 | -18.46 | 31.74 | 23.21 | 0.25 | 0 | 5.85 | 0 | 0.01 | 0 | 0.26 | 0 | 0.25 | 0 |
2018 (5) | 50 | 0.0 | -1.24 | 0 | -0.76 | 0 | 5.31 | -2.39 | 25.76 | -20.17 | -7.43 | 0 | -11.69 | 0 | -0.39 | 0 | -0.61 | 0 | -0.62 | 0 |
2017 (4) | 50 | 25.0 | 0.36 | 63.64 | -0.19 | 0 | 5.44 | 62.87 | 32.27 | -0.22 | -0.98 | 0 | 3.31 | 23.51 | -0.05 | 0 | 0.22 | 83.33 | 0.18 | 100.0 |
2016 (3) | 40 | 21.21 | 0.22 | 0 | 0.26 | 0 | 3.34 | 65.35 | 32.34 | 32.32 | 5.12 | 0 | 2.68 | 0 | 0.17 | 0 | 0.12 | 0 | 0.09 | 0 |
2015 (2) | 33 | -21.43 | -3.28 | 0 | -1.00 | 0 | 2.02 | -8.18 | 24.44 | 1.83 | -5.88 | 0 | -53.68 | 0 | -0.12 | 0 | -0.67 | 0 | -1.09 | 0 |
2014 (1) | 42 | 0.0 | -1.01 | 0 | -0.91 | 0 | 2.2 | -25.17 | 24.00 | 0 | -5.05 | 0 | -19.16 | 0 | -0.11 | 0 | -0.04 | 0 | -0.42 | 0 |